In addition to their metabolic effects, early studies suggested beneficial effects of GLP-1 analogues on cardiovascular function, including molecular mechanisms involved in atherogenesis, cardiovascular risk factors, ischemic heart disease, and heart failure (96, 243, 244)
5-Amino-1MQ is commonly studied in research settings for its interaction with metabolic pathways, particularly in relation to NNMT (Nicotinamide N-methyltransferase) activity, cellular energy regulation, and adipose tissue function
Semaglutide is a GLP-1 receptor agonist that mimics incretin hormones to enhance insulin secretion, delay gastric emptying, and suppress appetite
Both groups receiving SHR-5 demonstrated statistically significant enhancements in overall depressive symptoms, sleep disturbances, emotional dysregulation, and somatic complaints, whereas the placebo cohort exhibited no such clinical improvements